© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York
A Cross-Sectional Study to Investigate Long-Term Cognitive Function in People with Treated Pituitary Cushing's Disease
Received: December 30, 2005
First decision: April 4, 2006
Accepted: May 17, 2006
17 November 2006 (online)
Introduction: It has been proposed that exposure to high levels of endogenous steroids in untreated pituitary Cushing's disease damages hippocampal structures leading to impairment in learning and memory processes. We hypothesised that patients with treated pituitary Cushing's disease would perform significantly worse on tests of cognitive ability than those with nonfunctioning pituitary adenomas. Design: Sixteen adults with pituitary Cushing's disease (PCD) and 16 adults with non-functioning pituitary adenomas (NFA) undertook the following comprehensive neuropsychological assessments: National Adult Reading Test (NART: premorbid abilities), California Verbal Learning Test (CVLT 2 UK: learning and recall), Stroop (executive functioning), Trail-Making Test (TMT: executive functioning and attention), Adult Memory and Information Processing Battery (AMIPB: Information Processing Speed and Story Recall subtests). Results: There was no significant difference in premorbid IQ scores (NFA mean=101 SD=13; PCD mean=102, SD=13), in verbal learning nor any significant difference in the percentage of verbal material retained in story recall (AMIPB). Performance on higher executive tasks Stroop and TMT and on measures of information processing was similar. However, there were significant decrements between some mean scores for both groups and published normative data with a clear association between higher HADS depression scores and impaired objective memory and attention which was not specific to PCD. Conclusions: We found no difference in cognitive function between patients with PCD and NFA. The results suggest a discrepancy between patients’ subjective perception of functional cognitive impairments and objective findings on psychometric testing and point to the influence of affective symptoms on cognitive performance, particularly in Cushing's disease.
Glucocorticoids - pituitary adenoma - cognition
- 1 Austin MP, Mitchell P, Goodwin GM. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry. 2001; 178 200-206
- 2 Coughlan AK.
The Adult Memory and Information Processing Battery (AMIPB) Test Manual. Leeds, England: AK Coughlan 1985
- 3 Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001; 40 337-434
- 4 Delis DC, Kaplan E, Kramer JH, Ober BA.
California Verbal Learning Test-Second UK Edition (CVLT-II). The Psychological Corporation 2000
- 5 Dodrill CB. A neuropsychological battery for epilepsy. Epilepsia. 1978; 19 611-623
- 6 Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology. 2002; 27 367-383
- 7 Grattan-Smith PJ, Morris JGL, Shores EA, Batchelor J, Sparks RS. Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol Scand. 1992; 86 626-631
- 8 Guinan EM, Lowy C, Stanhope N, Lewis PDR, Kopelman MD. Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry. 1998; 65 870-876
- 9 Heald AH, Ghosh S, Bray S, Gibson C, Anderson SG, Buckler H, Fowler HL. Long-term negative impact on quality of life in patients with successfully treated Cushing's disease. Clin Endocrinol. 2004; 61 458-465
- 10 McCord M, Buatti J, Fennell E, Medenhall W, Marcus R, Rhoton A, Grant M, Friedman W. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. International J Radiation Oncol. 1997; 39 437-444
- 11 Mauri M, Sinforiani E, Bono G, Vignati F, Berselli ME, Attanasio R, Nap-pi G. Memory impairment in Cushing's disease. Acta Neurol Scand. 1993; 87 52-55
- 12 Nelson H, Wilson j.
The National Adult Reading Test (NART). 1984 Nfer Nelson
- 13 Noad R, Narayanan K, Hewlett T, Lincoln N, Page R. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clinic Oncol. 2004; 16 233-237
- 14 Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE. Cognitive dysfunction in patients treated for pituitary tumours. J Clin Experimental Neuropsychol. 1997; 19 1-6
- 15 Robertson IH, Ward T, Ridgeway V, Nimmo-Smith I.
Test of Everyday Attention (TEA). Thames Valley Test Company 1994
- 16 Ruddle HV, Bradshaw CM. On the estimation of premorbid intellectual functioning: validation of Nelson & McKenna's formula, and some new normative data. Br J Clin Psych. 1982; 21 159-165
- 17 Tombaugh TN, Rees L, Mclntyre N. Normative data for the Trail Making Test. In: Spreen O, Strauss E (eds) (1998).
Personal Communication. A compendium of neuropsychological tests. New York: Oxford University Press 1988
- 18 Spreen O, Strauss E.
A Compendium of Neuropsychological Tests. NewYork: Oxford University Press 1998
- 19 Starkman MN, Schteingart DE. Neuropsychiatric manifestations of patients with Cushing's Syndrome. Arch Intern Med. 1981; 141 215-219
- 20 Starkman MN, Gebarski SS, Berent S, Schteingart DE. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biological Psychiatry. 1992; 32 756-765
- 21 Starkman MN, Giordani B, Berent S, Schork A, Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosomatic Medicine. 2001; 63 985-993
- 22 Starkman MN, Giordani B, Gebarski SS, Schteingart DE. Improvement in learning associated with increase in hippocampal formation volume. Biological Psychiatry. 2003; 53 233-238
- 23 Surma-aho O, Niemela M, Vilkki j, Kouri M, Brander A, Salonen O, Pae- tau A, Kallio M, Pyykkonen j, jaaskelainen j. Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients. Neurology. 2001; 56 1285-1290
- 24 Warrington EK, James M.
Visual Object and Space Perception Battery (VOSP). Thames Valley Test Company 1991
- 25 Whelan TB, Schteingart DE, Starkman MD, Smith A. Neuropsycholog ical deficits in Cushing's Syndrome. j Nervous Mental Disease. 1980; 168 753-757
- 26 Zigmond AS, Snaith RP.
The Hospital Anxiety and Depression Scale. Nfer Nelson 1983
Hope Hospital·Department of Endocrinology and Diabetes
M6 8HD Salford
Phone: 00/44/16 12 06 51 46
Fax: 00/44/16 12 06 59 89